Drug intelligence / Profile preview

recombinant mussel mucin

Development stage
Unknown
Lead developer
JUYOU
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Recombinant mussel mucin is a genetically engineered protein biomaterial inspired by the natural adhesive proteins (mucins) found in marine mussels. It is typically produced using microbial expression systems such as *Pichia pastoris* or *Escherichia coli*, and consists of key peptide segments from native mussel foot proteins (e.g., Mfp-3, preCol-P). The resulting recombinant protein exhibits high purity and content of 3,4-dihydroxyphenylalanine (DOPA), a critical amino acid for adhesion and bioactivity[1][9]. Recombinant mussel mucin has demonstrated significant promotion of wound healing by enhancing fibroblast proliferation and migration at the cellular level and accelerating skin repair in animal models[1]. It also shows promise as an antimicrobial dressing for chronic inflammatory skin diseases due to its durable adhesion properties and ability to inhibit bacteria-induced toll-like receptor signaling[6]. Medical dressings based on this material are used for superficial non-chronic wounds, oral ulcers, compromised skin barriers, and potentially other tissue repair applications[2][4][10].

Other names
rMfp-3PrMfp3PrMfp 3PrMfp151rMfp-151rMfp 151co-rMfp-151co-rMfp151co-rMfp 151recombinant mussel adhesive protein

Beyond the preview

Go deeper on recombinant mussel mucin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant mussel mucin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call